Go to deals
Financial Services | Healthcare

Generali has expanded its footprint in Bulgaria by acquiring one of the top health insurers on the market

Doverie United Holding has successfully completed the sale of United Health Insurance Fund Doverie (Doverie) to Generali CEE Holding.

Doverie is one of the largest private health insurance companies in Bulgaria. As one of the first health insurance funds in the country, it ranked among the top three in 2024 by premium revenue.

Generali, the Italian insurance company and one of the world’s leading insurance providers, has acquired Doverie as part of its growth strategy in the Central and Eastern Europe (CEE) region. With this acquisition, Generali will become the second-largest player in Bulgaria’s health insurance market.

Doverie United Holding is a renowned publicly listed equity fund in Bulgaria, with a diverse portfolio that includes 18 companies across eight economic sectors.

Oaklins’ team in Bulgaria acted as the exclusive sell-side M&A adviser to Doverie United Holding, assisting the client throughout the entire divestment process.

Parties
“We are always pleased to observe how our investments and strategic direction promote our portfolio companies to scale their teams and expand their businesses. In the same way, with our support, United Health Insurance Fund Doverie has rightfully grown to become one of the top players in the Bulgarian health insurance market.

We are now delighted that, with this transaction, Doverie has found in Generali the strategic partner that can continue the development trajectory of the business and bring it to the next level of growth. We are also thankful to Oaklins’ Bulgarian team for its professionalism and dedication throughout the deal. They were instrumental in managing the relationship between all the stakeholders, the negotiation process and the execution of the transaction.”

Alexander Hristov

CEO, Doverie United Holding

Talk to the deal team

Ivan Angelov

Associate Director
Sofia, Bulgaria
Oaklins Karoll

Nasko Jordanov

Principal
Sofia, Bulgaria
Oaklins Karoll

Related deals

Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval
Healthcare

Instituto Sanitas and Chemopharma have been acquired by Laboratorios Saval

Instituto Sanitas and Chemopharma, leading pharmaceutical laboratories in Chile, have been acquired by Laboratorios Saval S.A., a prominent pharmaceutical company based in Chile with a regional presence across Latin America. The transaction strengthens Laboratorios Saval’s growth strategy and supports its expansion in the affordable medicines segment.

Learn more
Rare Patient Voice has been acquired by Konovo
Healthcare | TMT

Rare Patient Voice has been acquired by Konovo

Rare Patient Voice has been acquired by Konovo, a technology-first healthcare intelligence company backed by Fraser Healthcare Partners.

Learn more
Centerbridge Partners has announced a minority interest investment in Pure Cremation
Private Equity | Financial Services

Centerbridge Partners has announced a minority interest investment in Pure Cremation

Centerbridge Partners, L.P. has announced a structured minority interest investment in Pure Cremation. The investment includes both loan and equity instruments and is subject to regulatory approval, with completion expected in the first half of 2026.

Learn more